Roselabs Finance Limited has submitted a regulatory intimation to BSE Limited regarding an upcoming meeting of its Board of Directors. The meeting is scheduled for Friday, July 17, 2026.
The primary agenda for the board meeting is to consider and approve the un-audited financial results of the company for the quarter ended June 30, 2026. The board will also review the limited review report accompanying these financial results.
The company references its previous communication dated June 25, 2026, regarding the closure of the trading window for dealing in company shares. In accordance with the Company's Code of Conduct for Prevention of Insider Trading, the trading window remains closed for all designated persons effective from July 1, 2026. The closure will continue until 48 hours after the declaration of the financial results.